This discrepancy was partially explained in the paper of Coyle and colleagues, where a limit overlap between ALDH1A3-induced gene expression and ATRA-induced gene expression was found, suggesting that probably the function of ALDH1A3 in breast cancer progression extends beyond its role as retinaldehyde dehydrogenase [97]. This evidence concerns the gene ALDH1A3 and breast carcinoma.